Posts filtered by tags: Genomics[x]


 

Could genomics solve the climate change crisis?

Genomics is the study of genes and their functions. The branch of molecular biology presents the idea that the genome can be manipulated for added resilience against harm.Yale professor and editor Daniel C. Esty argues that genetic modification in nature as a way to improve sustainability should be seriously considered.In the book A Better Planet: Forty Big Ideas for a Sustainable Future, Esty and several authors offer actionable solutions for dealing with greenhouse gases, including genomic in...
Tags: Technology, Biology, Climate Change, Animals, Environment, Sustainability, Genetics, Yale, Innovation, Plants, Genomics, Global Issues, Daniel C Esty, Sustainable Future Esty


Mammoth Biosciences aims to be Illumina for the gene editing generation

In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material. Now, a little over twenty years later, Mammoth Biosciences is hoping to do the same thing for gene editing tools. The company, co-founded by Jennifer Doudna, who did some of the pioneering work to discover the gene editing enzyme known as CRISPR, has just raised $45 million as it looks to bring to market products that c...
Tags: TC, Tech, Genomics, Crispr, Alphabet, Illumina, Bayer, Martin, Cambridge UK, Bio Rad, Jennifer Doudna, Broad Institute, CRISPR Therapeutics, Mayfield, Trevor Martin, New York Law School


23andMe co-founder’s new startup, Precise.ly, brings genomics to India through Narayana partnership

Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with Naryana Health, one of India’s leading specialty hospital networks. Narayana, a company that operates a network of 24 hospitals serving 2.5 million patients, is one of the most fascinating stories in healthcare. By emphasizing efficiencies and cost savings, the hospital network has managed to bring...
Tags: TC, Asia, Biology, Cancer, India, Africa, Chief executive officer, Tech, Bloomberg, Genetics, Healthcare, Healthcare Industry, Disease, Genomics, Fda, Genetic Testing


23andMe co-founder’s new startup, Precise.ly, brings genomics to India through Narayana partnerhsip

Precise.ly, the new genomics startup launched by 23andMe co-founder Linda Avey and Aneil Mallavarapu, is taking its spin on direct to consumer personalized genomics to India through a partnership with Naryana Health, one of India’s leading specialty hospital networks. Narayana, a company that operates a network of 24 hospitals serving 2.5 million patients, is one of the most fascinating stories in healthcare. By emphasizing efficiencies and cost savings, the hospital network has managed to bring...
Tags: TC, Asia, Biology, Cancer, India, Africa, Chief executive officer, Tech, Bloomberg, Genetics, Healthcare, Healthcare Industry, Disease, Genomics, Fda, Genetic Testing


UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million Series A. The raise follows a $4M seed in February — taking its total raised to date to $20M. Put simply, Mogrify’s approach entails analysis of vast amounts of genomic data in order to identify the specific energetic changes needed to flip an adult cell from one type to another without having to reset ...
Tags: Health, Fundings & Exits, Europe, UK, New York, Biology, America, Tech, Artificial Intelligence, Chicago, United Kingdom, Cambridge, Disease, Genomics, Biotech, Stem Cell


Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis

Color Genomics, the genetics testing company, is partnering with Alphabet’s health technology focused subsidiary, Verily Life Sciences, to provide information from its genetic tests to the company’s Baseline Health Study participants. The emphasis from both companies is on providing “actionable” results. While genetic testing services have caught the public’s imagination for their ability to provide insights into an individual’s ancestry, the technology has proven to be less effective in providi...
Tags: Google, TC, Medicine, Tech, Genetics, Genomics, Genetic Testing, Alphabet, Verily, Color Genomics, Project Baseline Health


Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More

Lung injuries linked to electronic cigarettes have topped 800 cases, including 12 deaths, according to the Centers for Disease Control and Prevention. Public health officials aren’t sure whether the injuries are from legally sold products made by companies such as Juul, or from black-market items such as those that allow users to “vape” the active ingredient in marijuana. But concerns have prompted vaping product bans in several states.Former FDA commissioner Scott Gottlieb—a fierce critic of t...
Tags: Startups, Trends, Colorectal Cancer, Genomics, Fda, National, Epilepsy, GlaxoSmithKline, Novartis, Nancy Pelosi, Immunotherapy, Biotech, Vaccines, Medical Device, Donald Trump, Centers For Disease Control And Prevention


The Genomics Revolution Is Now Moving At Full Steam. Here’s What It’s All About:

We tend to think of innovation as a single event, but the truth is that it’s an extended process of discovery, engineering and transformation. First, a scientist discovers a new phenomenon, then others figure out to use that knowledge to create a viable solution to an existing problem and finally a particular industry or field ...
Tags: Innovation, Genomics, Health/Healthcare


Roundup: Strata Oncology, Genomenon, Gilbert Family Foundation, More

Spring is always a busy time for Michigan’s innovation community, so let’s catch up on recent tech and entrepreneurial news below:—Last year, we reported on the Gilbert Family Foundation, a charitable organization founded by Quicken Loans chairman Dan Gilbert and his wife Jennifer, and its initiative to develop gene therapy treatments for neurofibromatosis 1 (NF1). In April, the foundation announced a new gene therapy research effort: an $11 million vision restoration initiative, which is focus...
Tags: Startups, Roundup, Entrepreneurship, Trends, Innovation, Gm, Genomics, Michigan, Detroit, STEM education, Dan Gilbert, University Of Michigan, Mastermind, Jennifer, Jen Welter, Ashoka


Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks

A new startup wants to edit out the world’s biggest killer. Prominent cardiologist and geneticist Sekar Kathiresan is heading up a new company, Verve Therapeutics, that will develop gene-altering medicine to prevent heart attacks. Heart disease is the leading cause of death in the US and worldwide.“Imagine an injection, once in life, that safely confers enduring protection against heart attack in adults,” said Kathiresan, the director of the Center for Genomic Medicine at Massachusetts General ...
Tags: Startups, Boston, Massachusetts, Funding, US, Trends, Vc, Genetics, Heart Attack, Venture Capital, Disease, Genomics, Biotech, Verily, Life Sciences, Editas Medicine


Join Xconomy for Our 8th Annual Napa Summit, June 13-14

Google. Amazon. Genentech. Those are some of the companies you’ll hear from at this year’s Napa Summit, the Xconomy Retreat on Technology, Jobs, and Growth.This is our most special event of the year—the eighth year we’ve held it—and it’s limited to about 100 VIP guests. We’ll tackle big trends, challenges, and opportunities in areas like venture capital, software, genomics, digital medicine, education, and diversity. The program is interdisciplinary and highly interactive.It all takes place ove...
Tags: Google, Amazon, Startups, Technology, Events, Trends, Diversity, It, People, Vc, Software, Culture, Innovation, Venture Capital, Genomics, National


XGenomes is bringing DNA sequencing to the masses

As healthcare moves toward genetically tailored treatments, one of the biggest hurdles to truly personalized medicine is the lack of fast, low-cost genetic testing. And few people are more familiar with the problems of today’s genetic diagnostics tools than Kalim Mir, the 52-year-old founder of XGenomes, who has spent his entire professional career studying the human genome. “ Ultimately genomics is going to be the foundation for healthcare,” says Mir. “For that we need to move toward a sequenci...
Tags: TC, Y Combinator, England, Biology, Tech, Harvard, United States, United Kingdom, Healthcare, Genome, Yorkshire, Lasers, Genomics, Human Genome Project, Northern England, Biotechnology


Genomenon Raises $2.5M, Plans to Increase Work with Pharma Customers

Genomenon, the Ann Arbor, MI-based genomics search engine startup, has raised $2.5 million in what the company calls a “seed extension” round.The equity financing included investments by IrishAngels, a group founded by Notre Dame alumni; H.W. Kaufman Group; Invest Michigan; and all previous investors, including Genomenon CEO Mike Klein. He says the company will use the new capital to beef up commercial development, sales, and marketing. It also plans to add at least three employees, bringing it...
Tags: Startups, Entrepreneurship, Cancer, Trends, Vc, Software, Innovation, Venture Capital, Genomics, Biotech, Detroit, Notre Dame, Healthtech, University Of Michigan, Mastermind, Ann Arbor


SXSW Startups: Nebula

The founding team (left to right): Kamal Obbad, George Church, Dennis Grishin. The Forrest Four-Cast: February 6, 2019 Fifty diverse startups will aim to impress a panel of judges and a live audience with their skills, creativity and innovation at SXSW Pitch Presented by Cyndx. Winners in 10 categories will be announced at the Pitch Award Ceremony at 6:30 pm Sunday, March 10, at the Hilton Austin.A finalist in Augmented and Virtual Reality, which will pitch at 3:30 pm Saturday, March 9, Nebul...
Tags: Startups, Entrepreneurship, Startup, Data, Genomics, Sxsw, Harvard Medical School, George Church, Hugh Forrest, Hilton Austin, Austin Startups, Nebula Genomics, Kamal Obbad, Dennis Grishin, Cyndx Winners, Kamal Obbad George Church Dennis Grishin


Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies

Evan Nisselson Contributor Evan Nisselson is a partner at LDV Capital. More posts by this contributor Deep learning with synthetic data will democratize the tech industry The war over artificial intelligence will be won with visual data Visual assessment is critical to healthcare – whether that is a doctor peering down your throat as you say “ahhh” or an MRI of your brain. Since the X-ray was invented in 1895, medical imaging h...
Tags: Travel, Health, TC, Column, Technology, Medicine, Boston, Cancer, Syria, Artificial Intelligence, Stroke, Telecommunications, Healthcare, Disease, Genomics, Dementia


How to Keep the FBI From Accessing Your FamilyTreeDNA Results

If you want to keep your DNA data out of the hands of law enforcement, avoiding GEDmatch isn’t enough. Family Tree DNA recently admitted it allows law enforcement to use their service, and is actively working with the FBI on at least a handful of cases.Read more...
Tags: Privacy, Dna, Fbi, Genetics, Genomics, Lifehacks, Data Privacy, 23andMe, Ancestry, Family Tree DNA


Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed to net the company $3.3 million in seed financing from some of Canada’s busiest investors. For the Toronto-based company, the pitch isn’t just around bank...
Tags: TC, Biology, Toronto, Tech, Banking, Genetics, Canada, Healthcare, Genome, Genomics, Taylor, Chairman, Biotechnology, Emerging-technologies, Healthcare Technology, ACORN


Teen self-injects verses from the Bible and the Koran that have been transposed into DNA

In The first injection in a human being of macromolecules whose primary structure was developed from a religious text a French 16 year old named Adrien Locatelli describes how he paid Vector Builder $1300 to transcode verses from the Bible and the Koran into macromolecules and then injected one verse into each leg (the Bible verse was written into the DNA of an adeno-associated virus and injected into his left thigh; the Koran verse was encoded into DNA but not merged with a virus and was then ...
Tags: Post, Science, News, Teens, France, Religion, Genomics, Ucla, Grenoble, Locatelli, Sri Kosuri, Daniel Oberhaus Motherboard, Nam-shub Of Enki, Adrien Locatelli, Advanced Biosciences


What Are 10 Digital Health Trend’s Today’s ERA?

A lot has been dealt with software-based technology, connected devices, and data analytics. All the three has worked together in a variety of businesses. But now it is high time that this digital transformation entry into the healthcare sector and brings an impact on your lives and fitness too. It can bring a change in two ways: Bring an acute change in the quality of your lives on a large scale Both employers and the healthcare sector will experience far-fetched implications So, as a whole, i...
Tags: Business, Digital, Sales, Social Media, Genomics, World Health Organization, World Economic Forum, Organon, Find A Doctor, Health Trend, Digital Health Trend, Genomics Genomics


Wisconsin Watchlist: Gravy, Semba, Steamchain, OnCourse, GenoPalate

Time to catch up on recent headlines from Wisconsin’s innovation community:—Madison-based Gravy snagged the first investment from Rock River Capital Partners, which recently closed its debut fund. Rock River partner Andy Walker told Xconomy the venture funding round for Gravy totaled about $2 million. Other investors in the deal included MSA Capital, a Chinese firm that invests in “social e-commerce” companies, according to a press release.When Xconomy profiled Gravy last year, the company was ...
Tags: Deals, Startups, Mobile, Apps, Education, Trends, Tech, It, Vc, Software, Genetics, M&a, Wisconsin, Genomics, Bertelsmann, Gravy


Mice given an experimental gene therapy don't get fat, regardless of caloric intake

Researchers at Flinders University knocked out a gene known as RCAN1 in mice, hypothesizing that this would increase "non-shivering thermogenesis," which "expends calories as heat rather than storing them as fat" -- the mice were fed a high-calorie diet and did not gain weight. In particular, the modified mice did not store fat around their middles -- a phenomenon associated with many health risks, including cardiac problems -- and their resting muscles burned more calories. I wrote this i...
Tags: Post, Science, News, Biology, Diet, Obesity, Scholarship, Genomics, Damien, Beverly, Flinders University, Calcineurin, Fatkins, Rcan1, Gavin Butler, Flinders University Science Daily


Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More

This was one of those weeks when the world seemed to slip into a new era with no going back. A Chinese researcher, He Jiankui, claimed he helped bring to life two genetically engineered babies, twin girls with a gene disabled to make them immune to HIV infection. Even though the technology He used—in vitro fertilization, CRISPR-Cas9 gene editing, deep sequencing—has been in place for some time to attempt the creation of a gene-altered human, the scientific world hoped for three years that self-...
Tags: Deals, Hong Kong, Scandal, White House, China, Trends, Investment, Fail, People, Vc, Leukemia, Lung Cancer, Ireland, Venture Capital, Genomics, Private Equity


Nebula Genomics Touts Free DNA Sequencing to Coax Health Data Sharing

A growing number of startups are trying to encourage people to share genomic and other health data for research purposes by offering them some form of compensation. Now, as competition in this young sector ramps up, one of the big questions is what type of incentive will attract the most individuals.The latest experiment comes from Nebula Genomics, the San Francisco- and Boston-based startup co-founded last year by Harvard University professor and genomics pioneer George Church, and backed by $...
Tags: Google, Startups, Facebook, Privacy, Boston, San Francisco, Trends, Tech, Data, Analytics, Vc, Software, Harvard, Harvard University, Genomics, Cryptocurrency


If you're an American of European descent, your stupid cousins have probably put you in vast commercial genomic databases

Remember when they caught the Golden State Killer by comparing DNA crime-scene evidence to big commercial genomic databases (like those maintained by Ancestry.com, 23 and Me, etc) to find his family members and then track him down? It's not just him. If you're an American of US descent, there's a 60% chance that you can be identified from genomic database searches, because even if you've never signed up for one of these junk science services, your stupid cousins have. That's the conclusio...
Tags: Security, Post, News, Privacy, US, Infosec, Genomics, Junk Science, Columbia, Forensics, Hebrew University of Jerusalem, Genetic Privacy, Families They Fuck You Up, Yaniv Erlich Tal Shor Itsik Pe'er, Shai Carmi Science


Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows

The humble cell has been getting a lot of attention in the medical world lately, and Ann Arbor, MI-based biotech startup Celsee wants to make it easier to study them.As precision medicine and genomic analysis become more sophisticated, clinicians are taking biotech research down to the level of single cells in search of breakthroughs that might not be visible when studying a large population of cells or tissues.Researchers say much can be gleaned about the progression of diseases like cancer an...
Tags: Startups, Entrepreneurship, Trends, Innovation, Genomics, Biotech, Detroit, Ann Arbor, Oncology, John Stark, National blog main, Detroit blog main, Detroit top stories, Precision Medicine, Celsee, Flow Cytometry


Plan to Build a Genetic Noah’s Ark Includes a Staggering 66,000 Species

An international consortium involving over 50 institutions has announced an ambitious project to assemble high-quality genome sequences of all 66,000 vertebrate species on Earth, including all mammals, birds, reptiles, amphibians, and fish. With an estimated total cost of $600 million dollars, it’s a project of…Read more...
Tags: Science, Biology, Animals, Earth, Noah, Genomics, Endangered Species, Biotechnology, Genetic Sequencing, Vertebrate Genomes Project, G10k


Roundup Part I: TechHire Bootcamp, Genomenon, Leading2Lean, Cengage

Time flies when you’re working hard. Although summer is nearly over, Michigan’s startup clusters keep humming along. In fact, so much is happening, we’ve divided this roundup into two parts. Part two will run Sept. 4. Read on for recent innovation news from around the state.—Detroiters age 18 and older have until Friday to apply for Grand Circus’s Tech Hire Bootcamp, a free 12-week tech training program that prepares students to immediately enter the workforce as entry-level developers. All boo...
Tags: Startups, Roundup, Entrepreneurship, Trends, It, Innovation, Genomics, Michigan, Manufacturing, Accenture, Detroit, Meridian, National blog main, Detroit blog main, Detroit top stories, Educational Technology


Genomics raises £25m as it announces deal with US pharma giant

Oxford biotech Genomics has raised £25m from investors and announced a collaboration with US pharmaceuticals giant Vertex that might eventually be worth tens of millions of pounds for the small UK genetics company. Investors in this latest round of funding, which brings the total raised by the company so far to £36m, include Woodford Investment Management, IP Group, Invesco Perpetual, Oxford Sciences Innovation and Vertex Pharmaceuticals, which invested £10.5m. Genomics was founded in 2014 by fo...
Tags: UK, Science, US, Genomics, GlaxoSmithKline, Amgen, Donnelly, Biogen, Vertex, Vertex Pharmaceuticals, Peter Donnelly, Vertex Genomics, Oxford biotech Genomics


George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs. Nebula has also has forged a partnership with genome sequencing company Veritas Genetics. Veritas was one of the fir...
Tags: Health, Startups, TC, Science, Biology, Privacy, Big Data, Funding, Tech, Ceo, Smartphone, Mit, Genetics, Genomics, Biotech, Bio


Regifting ideas: How an obscure idea from animal breeding helps us to understand genome evolution

One of the more satisfying aspects of science is that an often fairly technical or obscure idea from one field can later turn out to be a key guiding principle in another, rather distant, field. One such example is a historical result from the theory of animal breeding that now provides critical insight into the way evolution structures genomes.One of the early observations from DNA sequencing studies was the finding that regions where the rate of gene exchange between chromosomal pairs (recombi...
Tags: Books, Featured, Dna, Breeding, Genetics, Genomics, Evolution, Charles Darwin, Chromosome, University of Edinburgh, Health & Medicine, Genetic Mutation, Michael Lynch, Alan Robertson, Science & Medicine, Earth & Life Sciences